KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $5.93.

  • Amgen's EPS (Weighted Average and Diluted) rose 1360.15% to $5.93 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.94, marking a year-over-year increase of 6547.31%. This contributed to the annual value of $7.56 for FY2024, which is 3947.1% down from last year.
  • Amgen's EPS (Weighted Average and Diluted) amounted to $5.93 in Q3 2025, which was up 1360.15% from $2.65 recorded in Q2 2025.
  • In the past 5 years, Amgen's EPS (Weighted Average and Diluted) registered a high of $5.93 during Q3 2025, and its lowest value of -$0.21 during Q1 2024.
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $2.83 (2021), whereas its average is $2.85.
  • Per our database at Business Quant, Amgen's EPS (Weighted Average and Diluted) tumbled by 10397.68% in 2024 and then soared by 162380.95% in 2025.
  • Amgen's EPS (Weighted Average and Diluted) (Quarter) stood at $3.35 in 2021, then dropped by 10.45% to $3.0 in 2022, then crashed by 52.33% to $1.43 in 2023, then decreased by 18.95% to $1.16 in 2024, then soared by 411.66% to $5.93 in 2025.
  • Its EPS (Weighted Average and Diluted) was $5.93 in Q3 2025, compared to $2.65 in Q2 2025 and $3.2 in Q1 2025.